Search Results
Search for other papers by Peiwen Wu in
Google Scholar
PubMed
Search for other papers by Dongjie He in
Google Scholar
PubMed
Search for other papers by Hao Chang in
Google Scholar
PubMed
Search for other papers by Xiaozhi Zhang in
Google Scholar
PubMed
). Methods Data source and case selection This study used the Surveillance, Epidemiology, and End Results (SEER) 18 registry program (2000–2018) for epidemiological and survival analyses. We used histology codes from the International Classification of
Search for other papers by Sonja Kunz in
Google Scholar
PubMed
Search for other papers by Xiao Wang in
Google Scholar
PubMed
Search for other papers by Uta Ferrari in
Google Scholar
PubMed
Search for other papers by Michael Drey in
Google Scholar
PubMed
Search for other papers by Marily Theodoropoulou in
Google Scholar
PubMed
Search for other papers by Katharina Schilbach in
Google Scholar
PubMed
Search for other papers by Martin Reincke in
Google Scholar
PubMed
KORA Study Centre, University Hospital of Augsburg, Augsburg, Augsburg, Germany
Search for other papers by Margit Heier in
Google Scholar
PubMed
German Centre for Cardiovascular Research (DZHK), Partner site Munich Heart Alliance, Munich, Germany
Search for other papers by Annette Peters in
Google Scholar
PubMed
German Heart Centre Munich, Technical University of Munich, Munich, Germany
Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany
Search for other papers by Wolfgang Koenig in
Google Scholar
PubMed
German Centre for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Hamburg, Germany
Search for other papers by Tanja Zeller in
Google Scholar
PubMed
Search for other papers by Barbara Thorand in
Google Scholar
PubMed
Search for other papers by Martin Bidlingmaier in
Google Scholar
PubMed
. Assessing obesity: classification and epidemiology . British Medical Bulletin 1997 53 238 – 252 . ( https://doi.org/10.1093/oxfordjournals.bmb.a011611 ) 27 Plebani M . Quality indicators to detect pre-analytical errors in laboratory testing . Clinical
Department of Public Health, Erasmus University Medical Center, Rotterdam, Netherlands
Search for other papers by Josephina G Kuiper in
Google Scholar
PubMed
Department of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
Search for other papers by Aline C Fenneman in
Google Scholar
PubMed
Search for other papers by Anne H van der Spek in
Google Scholar
PubMed
Search for other papers by Elena Rampanelli in
Google Scholar
PubMed
Department of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
Search for other papers by Max Nieuwdorp in
Google Scholar
PubMed
Search for other papers by Myrthe P P van Herk-Sukel in
Google Scholar
PubMed
Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands
Search for other papers by Valery E P P Lemmens in
Google Scholar
PubMed
Search for other papers by Ernst J Kuipers in
Google Scholar
PubMed
Department of Epidemiology and Data Science, Amsterdam UMC, Amsterdam, Netherlands
Search for other papers by Ron M C Herings in
Google Scholar
PubMed
Search for other papers by Eric Fliers in
Google Scholar
PubMed
2000 3 417 – 426 . ( https://doi.org/10.1046/j.1524-4733.2000.36006.x ) 18 Taylor PN Albrecht D Scholz A Gutierrez-Buey G Lazarus JH Dayan CM Okosieme OE . Global epidemiology of hyperthyroidism and hypothyroidism . Nature Reviews
Search for other papers by J Gebauer in
Google Scholar
PubMed
Search for other papers by R Skinner in
Google Scholar
PubMed
Search for other papers by R Haupt in
Google Scholar
PubMed
Amsterdam UMC, Emma’s Children’s Hospital, Amsterdam, The Netherlands
Search for other papers by L Kremer in
Google Scholar
PubMed
Search for other papers by H van der Pal in
Google Scholar
PubMed
Search for other papers by G Michel in
Google Scholar
PubMed
Search for other papers by G T Armstrong in
Google Scholar
PubMed
Search for other papers by M M Hudson in
Google Scholar
PubMed
Search for other papers by L Hjorth in
Google Scholar
PubMed
Search for other papers by H Lehnert in
Google Scholar
PubMed
Search for other papers by T Langer in
Google Scholar
PubMed
Many long-term childhood cancer survivors suffer from treatment-related late effects, which may occur in any organ and include a wide spectrum of conditions. Long-term follow-up (LTFU) is recommended to facilitate early diagnosis and to ensure better health outcomes. Due to the heterogeneity of these sequelae, different specialists work together in the diagnosis and treatment of these conditions. Experts from both pediatric and internal medicine are involved in age-appropriate care by providing a transition process. Hence, LTFU of childhood cancer survivors is a prototypic example of multidisciplinary care for patients with complex needs treated in a specialized setting. International collaborations of healthcare professionals and scientists involved in LTFU of childhood cancer survivors, such as the International Guideline Harmonization Group, compile surveillance recommendations that can be clinically adopted all over the world. These global networks of clinicians and researchers make a joint effort to address gaps in knowledge, increase visibility and awareness of cancer survivorship and provide an excellent example of how progress in clinical care and scientific research may be achieved by international and multidisciplinary collaboration.
Search for other papers by Kazhan Mollazadegan in
Google Scholar
PubMed
Search for other papers by Britt Skogseid in
Google Scholar
PubMed
Search for other papers by Johan Botling in
Google Scholar
PubMed
Search for other papers by Tobias Åkerström in
Google Scholar
PubMed
Search for other papers by Barbro Eriksson in
Google Scholar
PubMed
Search for other papers by Staffan Welin in
Google Scholar
PubMed
Search for other papers by Anders Sundin in
Google Scholar
PubMed
Search for other papers by Joakim Crona in
Google Scholar
PubMed
Epidemiology Guidelines ( 18 ). Study design, setting and participants This was a single-center retrospective cohort study at Uppsala University Hospital, Uppsala, Sweden. Patients were included when they fulfilled the following criteria: (i
Search for other papers by Kaili Yang in
Google Scholar
PubMed
Search for other papers by Jiarui Li in
Google Scholar
PubMed
Search for other papers by Yuejuan Cheng in
Google Scholar
PubMed
Search for other papers by Chunmei Bai in
Google Scholar
PubMed
landscape and chronological changes of clinical trials in GEP-NENs. This study was conducted according to the Strengthening the Reporting of Observational studies in Epidemiology (STROBE) guideline and was exempt from institutional board review because it
Search for other papers by Hélène Singeisen in
Google Scholar
PubMed
Search for other papers by Mariko Melanie Renzulli in
Google Scholar
PubMed
Search for other papers by Vojtech Pavlicek in
Google Scholar
PubMed
Search for other papers by Pascal Probst in
Google Scholar
PubMed
Search for other papers by Fabian Hauswirth in
Google Scholar
PubMed
Search for other papers by Markus K Muller in
Google Scholar
PubMed
Search for other papers by Magdalene Adamczyk in
Google Scholar
PubMed
Search for other papers by Achim Weber in
Google Scholar
PubMed
Search for other papers by Reto Martin Kaderli in
Google Scholar
PubMed
Search for other papers by Pietro Renzulli in
Google Scholar
PubMed
multiple endocrine neoplasia 2A in Denmark 1901–2014: a nationwide study . Clinical Epidemiology 2018 10 1479 – 1487 . ( https://doi.org/10.2147/CLEP.S174606 ) 11 Mathiesen JS Kroustrup JP Vestergaard P Madsen M Stochholm K Poulsen PL Krogh
Search for other papers by Carole Morin in
Google Scholar
PubMed
Search for other papers by Keo-Morakort Benedetto in
Google Scholar
PubMed
Centre de Recherche en Cancérologie de Lyon, UMR Inserm 1052 CNRS 5286, Lyon Cedex 08, France
Search for other papers by Agathe Deville in
Google Scholar
PubMed
University of Lyon, Université Lyon 1, France
Search for other papers by Laurent Milot in
Google Scholar
PubMed
Search for other papers by Aurélie Theillaumas in
Google Scholar
PubMed
University of Lyon, Université Lyon 1, France
Hospices Civils de Lyon, Institut de Pathologie Est, Bron Cedex, France
Search for other papers by Valérie Hervieu in
Google Scholar
PubMed
Hospices Civils de Lyon, Hôpital Edouard Herriot, Gastroentérologie, Lyon Cedex 03, France
Search for other papers by Mathieu Pioche in
Google Scholar
PubMed
University of Lyon, Université Lyon 1, France
Hospices Civils de Lyon, Hôpital Edouard Herriot, Chirurgie Digestive, Lyon Cedex 03, France
Search for other papers by Gilles Poncet in
Google Scholar
PubMed
Search for other papers by Julien Forestier in
Google Scholar
PubMed
Search for other papers by Laurent François in
Google Scholar
PubMed
Hospices Civils de Lyon, Hôpital Louis Pradel, Endocrinologie, Bron Cedex, France
Search for other papers by Francoise Borson-Chazot in
Google Scholar
PubMed
Hospices Civils de Lyon, Hôpital Edouard Herriot, Chirurgie Digestive, Lyon Cedex 03, France
Search for other papers by Mustapha Adham in
Google Scholar
PubMed
Search for other papers by Catherine Lombard-Bohas in
Google Scholar
PubMed
Centre de Recherche en Cancérologie de Lyon, UMR Inserm 1052 CNRS 5286, Lyon Cedex 08, France
University of Lyon, Université Lyon 1, France
Search for other papers by Thomas Walter in
Google Scholar
PubMed
’: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States . Journal of Clinical Oncology 2008 26 3063 – 3072 . ( https://doi.org/10.1200/JCO.2007.15.4377 ) 2 Hallet J Law CHL Cukier M Saskin R Liu N Singh
Search for other papers by Malgorzata Fuksiewicz in
Google Scholar
PubMed
Search for other papers by Maria Kowalska in
Google Scholar
PubMed
Search for other papers by Agnieszka Kolasinska-Cwikla in
Google Scholar
PubMed
Search for other papers by Beata Kotowicz in
Google Scholar
PubMed
data obtained in the framework of the Surveillance, Epidemiology and End Results (SEER) Program of the National Cancer Institute associates the increase in the incidence with an improvement in the diagnosis of neuroendocrine tumours ( 14 ). In this
Search for other papers by Matteo Scopel in
Google Scholar
PubMed
Search for other papers by Eugenio De Carlo in
Google Scholar
PubMed
Search for other papers by Francesca Bergamo in
Google Scholar
PubMed
Search for other papers by Sabina Murgioni in
Google Scholar
PubMed
Search for other papers by Riccardo Carandina in
Google Scholar
PubMed
Search for other papers by Anna Rita Cervino in
Google Scholar
PubMed
Search for other papers by Marta Burei in
Google Scholar
PubMed
Search for other papers by Federica Vianello in
Google Scholar
PubMed
Search for other papers by Vittorina Zagonel in
Google Scholar
PubMed
Search for other papers by Matteo Fassan in
Google Scholar
PubMed
Search for other papers by Roberto Vettor in
Google Scholar
PubMed
tumours in the European Union . Annals of Oncology 2016 27 vi139. ( https://doi.org/10.1093/ANNONC/MDW369.09 ) 5 Riihimäki M Hemminki A Sundquist K Sundquist J Hemminki K . The epidemiology of metastases in neuroendocrine tumors